Detalhe da pesquisa
1.
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Exp Parasitol
; 260: 108743, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513973
2.
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Exp Parasitol
; 199: 30-37, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817917
3.
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.
Pathogens
; 12(2)2023 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36839586
4.
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Acta Trop
; 191: 29-37, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586571
5.
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection.
Biomed Pharmacother
; 109: 779-787, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30551531
6.
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Parasitol Int
; 68(1): 63-72, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339837